Order Article Reprints

Skarlis C, Marketos N, Nezos A, Papanikolaou A, Voulgarelis M, Koutsilieris M, Moutsopoulos HM, Mavragani CP. +3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications. Journal of Clinical Medicine. 2021; 10(17):3960. https://doi.org/10.3390/jcm10173960

Skarlis, Charalampos, Nikolaos Marketos, Adrianos Nezos, Asimina Papanikolaou, Michael Voulgarelis, Michael Koutsilieris, Haralampos M. Moutsopoulos, and Clio P. Mavragani. 2021. "+3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications" Journal of Clinical Medicine 10, no. 17: 3960. https://doi.org/10.3390/jcm10173960

Skarlis, C., Marketos, N., Nezos, A., Papanikolaou, A., Voulgarelis, M., Koutsilieris, M., Moutsopoulos, H. M., & Mavragani, C. P. (2021). +3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications. Journal of Clinical Medicine, 10(17), 3960. https://doi.org/10.3390/jcm10173960